Published in J Clin Pathol on September 14, 2007
EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J (2012) 1.91
Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn (2008) 1.82
Noncoding RNA-guided recruitment of transcription factors: A prevalent but undocumented mechanism? Bioessays (2015) 1.40
microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res (2010) 1.32
The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res (2009) 1.31
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. Clin Cancer Res (2011) 1.25
High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma. Lab Invest (2008) 1.10
AIDS-Related EBV-Associated Smooth Muscle Tumors: A Review of 64 Published Cases. Patholog Res Int (2011) 1.04
MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing. PLoS One (2012) 0.95
Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies. Mol Ther (2009) 0.94
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival. EBioMedicine (2015) 0.92
Epstein-Barr virus microRNAs and lung cancer. Br J Cancer (2011) 0.91
Characterization of Epstein Barr virus latency pattern in Argentine breast carcinoma. PLoS One (2010) 0.90
Tpl2/AP-1 enhances murine gammaherpesvirus 68 lytic replication. J Virol (2009) 0.86
The Role of microRNAs in the Pathogenesis of Herpesvirus Infection. Viruses (2016) 0.85
Replication and transcription activator (RTA) of murine gammaherpesvirus 68 binds to an RTA-responsive element and activates the expression of ORF18. J Virol (2011) 0.83
EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda. Infect Agent Cancer (2010) 0.83
An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA. J Virol (2012) 0.82
Distribution and Molecular Characterization of Human Adenovirus and Epstein-Barr Virus Infections in Tonsillar Lymphocytes Isolated from Patients Diagnosed with Tonsillar Diseases. PLoS One (2016) 0.80
Pathology of epstein-barr virus-associated gastric carcinoma and its relationship to prognosis. Gut Liver (2011) 0.79
Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms. J Clin Microbiol (2012) 0.79
A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog. PLoS Pathog (2016) 0.79
The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers. Oncotarget (2016) 0.79
Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders. Exp Mol Med (2015) 0.77
Virus and autoantigen-specific CD4+ T cells are key effectors in a SCID mouse model of EBV-associated post-transplant lymphoproliferative disorders. PLoS Pathog (2014) 0.76
miRNA expression profiling of Epstein-Barr virus-associated NKTL cell lines by Illumina deep sequencing. FEBS Open Bio (2016) 0.76
The expression of a viral microRNA is regulated by clustering to allow optimal B cell transformation. Nucleic Acids Res (2015) 0.75
The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma. J Cancer (2017) 0.75
Clinicopathological features of 11 Epstein-Barr virus-associated intrahepatic cholangiocarcinoma at a single center in China. Medicine (Baltimore) (2016) 0.75
Herpesviral microRNAs in Cellular Metabolism and Immune Responses. Front Microbiol (2017) 0.75
Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med (2004) 5.61
Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood (1997) 4.36
Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol (1992) 3.33
Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol (2004) 3.09
The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med (1995) 2.68
Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol (2001) 2.55
Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med (1995) 2.38
Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol (2004) 2.30
Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17-24 June 1997. IARC Monogr Eval Carcinog Risks Hum (1997) 2.28
Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor. Hum Pathol (1995) 2.22
CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol (2004) 1.97
Malignant tumours following immunosuppressive therapy. Can Med Assoc J (1970) 1.97
Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res (1995) 1.96
Epstein-Barr virus and gastric carcinoma. Mol Pathol (2000) 1.94
Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res (2000) 1.72
Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci U S A (2006) 1.70
Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma. Lancet (2003) 1.70
EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol (2004) 1.68
Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol (2005) 1.61
Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer (2001) 1.55
The antibody 2B4 directed against the Epstein-Barr virus (EBV)-encoded nuclear antigen 1 (EBNA1) detects MAGE-4: implications for studies on the EBV association of human cancers. J Pathol (2006) 1.55
Pyothorax-associated lymphoma: a review of 106 cases. J Clin Oncol (2002) 1.54
Plasmablastic lymphoma: a clinicopathologic correlation. Ann Diagn Pathol (2006) 1.54
Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood (1996) 1.50
Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol (2006) 1.50
Non-Hodgkin's lymphoma, coeliac disease, and Epstein-Barr virus: a study of 13 cases of enteropathy-associated T- and B-cell lymphoma. J Pathol (1995) 1.49
Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am J Pathol (1993) 1.43
Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications. Cancer Surv (1997) 1.43
Plasmablastic lymphoma in HIV+ patients: an expanding spectrum. Histopathology (2003) 1.41
Epstein-Barr virus in gastric carcinoma. Am J Pathol (1993) 1.40
Follicular dendritic cell tumor of the liver. Evidence for an Epstein-Barr virus-related clonal proliferation of follicular dendritic cells. Am J Surg Pathol (1996) 1.28
Inflammatory pseudotumor of the liver. Evidence for follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus. Am J Surg Pathol (1996) 1.27
Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood (1992) 1.26
Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol (2007) 1.26
Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients. Am J Surg Pathol (2006) 1.20
Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology (1999) 1.17
Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol (2007) 1.16
Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review. J Clin Exp Hematop (2006) 1.13
Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load. Br J Haematol (2007) 1.11
Absence of Epstein-Barr virus DNA in the tumor cells of European hepatocellular carcinoma. Virology (2003) 1.10
Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol (2002) 1.10
Epstein-Barr virus-associated carcinomas: facts and fiction. J Pathol (2003) 1.07
Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features. Am J Surg Pathol (2001) 1.07
Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection. Am J Surg Pathol (1995) 1.06
Epstein-Barr virus detection in ductal carcinoma of the breast. J Natl Cancer Inst (2001) 1.06
Epstein-Barr virus (EBV) in enteropathy-associated T-cell lymphoma (EATL). J Pathol (1993) 1.04
Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. Int J Cancer (2007) 1.04
Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases. Am J Surg Pathol (2006) 1.03
Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma. J Exp Med (2001) 1.03
Molecular histogenesis of posttransplantation lymphoproliferative disorders. Blood (2003) 1.03
T-cell and NK-cell posttransplantation lymphoproliferative disorders. Am J Clin Pathol (2007) 1.00
Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood (1992) 0.99
Epstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation. J Virol (2007) 0.98
Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types. J Pathol (1995) 0.95
Association of Epstein-Barr virus with oral cancers. Hum Pathol (2002) 0.94
Richter's transformation in chronic lymphocytic leukemia. Semin Oncol (2006) 0.94
Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma. J Oral Pathol Med (2004) 0.92
Epstein-Barr virus latent membrane protein-1 (LMP-1) expression in oral squamous cell carcinoma. Laryngoscope (2002) 0.92
Absence of Epstein-Barr virus in anaplastic large cell lymphoma: a study of 64 cases classified according to World Health Organization criteria. Hum Pathol (2004) 0.88
ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases. Am J Surg Pathol (2006) 0.85
Epstein-Barr virus in breast cancer: artefact or aetiological agent? J Pathol (2006) 0.84
Lymphomatoid granulomatosis--a report on four cases: evidence for B phenotype of the tumoral cells. Eur Respir J (1998) 0.83
Loss of expression of Epstein-Barr virus nuclear antigen-2 correlates with a poor prognosis in cases of pyothorax-associated lymphoma. Int J Cancer (2006) 0.82
Epstein-Barr virus in CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea. Int J Dermatol (2006) 0.80
No direct role for Epstein-Barr virus in American hepatocellular carcinoma. Am J Pathol (2001) 0.80
Unlikely role of Epstein-Barr virus in the pathogenesis of primary cutaneous CD30+ anaplastic large cell lymphoma. Eur J Dermatol (2001) 0.79
[Senile EBV-associated B-cell lymphoproliferative disorder]. Uirusu (2003) 0.76
Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol (2001) 2.70
Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys (1991) 2.48
Residual disease following unplanned excision of soft-tissue sarcoma of an extremity. J Bone Joint Surg Am (1996) 2.26
Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection. Proc Natl Acad Sci U S A (2002) 1.99
Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis (2010) 1.98
Controversies in the management of non-small cell lung cancer: the results of an expert surrogate study. Radiother Oncol (1990) 1.88
The surgical margin in soft-tissue sarcoma. J Bone Joint Surg Am (1989) 1.86
An analysis of 78 breast sarcoma patients without distant metastases at presentation. Int J Radiat Oncol Biol Phys (2000) 1.82
Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys (1994) 1.82
The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation (1996) 1.75
Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys (1995) 1.70
Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment. Br J Cancer (1989) 1.68
How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol (1988) 1.65
The influence of anatomic location on functional outcome in lower-extremity soft-tissue sarcoma. Ann Surg Oncol (2004) 1.64
The impact of residual disease on local recurrence in patients treated by initial unplanned resection for soft tissue sarcoma of the extremity. J Surg Oncol (1997) 1.61
Local control of soft tissue sarcoma of the extremity: the experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy. Eur J Cancer (1994) 1.60
Paratesticular sarcoma: failure patterns after definitive local therapy. J Urol (1999) 1.59
Adult paratesticular sarcomas: a review of 21 cases. J Urol (1991) 1.59
The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer. Br J Cancer (1986) 1.53
Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol (1996) 1.50
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol (2002) 1.50
A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys (1993) 1.50
The inguinal sarcoma: a review of five cases. Can J Surg (1990) 1.48
Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys (1995) 1.44
Combined radiation therapy, mitomycin C, and 5-fluorouracil for locally recurrent rectal carcinoma: results of a pilot study. Int J Radiat Oncol Biol Phys (1991) 1.43
Mixed hydroxypyridinonate ligands as iron chelators. Inorg Chem (2000) 1.43
Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J Bone Joint Surg Br (2001) 1.43
A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example. Cancer (1997) 1.41
Soft tissue sarcomas involving the pelvis. J Surg Oncol (2001) 1.40
Long-term follow-up of efficacy and safety of megavoltage radiotherapy in high-risk giant cell tumors of bone. Int J Radiat Oncol Biol Phys (1995) 1.38
GLEE, a new computer program for glass electrode calibration. Talanta (2000) 1.33
Wound-healing complications after soft-tissue sarcoma surgery. Plast Reconstr Surg (1994) 1.29
Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res (1998) 1.29
Mammographic signs as risk factors for breast cancer. Br J Cancer (1982) 1.28
Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys (1993) 1.26
Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. Arthritis Rheum (2000) 1.22
Cellular transcription factors recruit viral replication proteins to activate the Epstein-Barr virus origin of lytic DNA replication, oriLyt. EMBO J (1999) 1.21
Synthesis of a ligand based upon a new entry into the 3-hydroxy-N-alkyl-2(1H)-pyridinone ring system and thermodynamic evaluation of its gadolinium complex. Inorg Chem (2000) 1.21
Predictors of functional outcomes following limb salvage surgery for lower-extremity soft tissue sarcoma. J Surg Oncol (2000) 1.21
An unusual case of duodenal obstruction-gangliocytic paraganglioma. J Hepatobiliary Pancreat Surg (2009) 1.21
Neurogenic sarcomas: experience at the University of Toronto. Neurosurgery (1998) 1.13
Non-small cell lung cancer: how oncologists want to be treated. Int J Radiat Oncol Biol Phys (1987) 1.12
Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys (1998) 1.11
Limb salvage surgery and adjuvant radiotherapy for soft tissue sarcomas of the forearm and hand. J Hand Surg Am (1997) 1.09
Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy. Cell Death Differ (2009) 1.08
Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcoma. Sarcoma (2011) 1.07
Peritoneal lavage cytology in patients with oesophagogastric adenocarcinoma. Br J Surg (2008) 1.06
The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys (1996) 1.06
Explaining socioeconomic status effects in laryngeal cancer. Clin Oncol (R Coll Radiol) (2006) 1.05
Preoperative and postoperative irradiation of soft tissue sarcomas: effect of radiation field size. Int J Radiat Oncol Biol Phys (1991) 1.02
Shape and roughness activate different somatosensory areas in the human brain. Proc Natl Acad Sci U S A (1998) 1.02
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas. Br J Cancer (2006) 1.00
Carcinoma of the maxillary antrum: a retrospective analysis of 110 cases. Radiother Oncol (2000) 1.00
Function after subtotal scapulectomy for neoplasm of bone and soft tissue. J Bone Joint Surg Br (1998) 1.00
A rare presentation of zygomycosis (mucormycosis) and review of the literature. J Clin Pathol (2005) 0.99
Spontaneous activation of the lytic cycle in cells infected with a recombinant Kaposi's sarcoma-associated virus. J Virol (2001) 0.99
Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am J Physiol Gastrointest Liver Physiol (2006) 0.99
Reconstructive options in the treatment of osteoradionecrosis of the craniomaxillofacial skeleton. Br J Plast Surg (2003) 0.99
A comparison of published head and neck stage groupings in carcinomas of the tonsillar region. Cancer (2001) 0.98
Outcome and analysis of the surgical management of esthesioneuroblastoma. J Otolaryngol (1997) 0.98
Preoperative radiotherapy is effective in the treatment of fibromatosis. Clin Orthop Relat Res (2003) 0.97
An assessment of prognostic factors in soft-tissue sarcoma of the head and neck. Arch Otolaryngol Head Neck Surg (1994) 0.96
Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles? J Clin Epidemiol (2001) 0.96
Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States. Cancer (2000) 0.95
Kumada-Corriu reactions in a pressure-driven microflow reactor. Lab Chip (2001) 0.94
T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys (1998) 0.93
Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells. EMBO J (1993) 0.93
Constructed wetlands for environmental pollution control: a review of developments, research and practice in Ireland. Environ Int (2007) 0.92
Recent progress in the management of retroperitoneal sarcoma. Sarcoma (2001) 0.92
Undetected cardiac lesions cause unexpected sudden cardiac death during occasional sport activity. A report of 80 cases. Eur Heart J (1999) 0.92
Functional outcome in patients treated with surgery and irradiation for soft tissue tumours. J Surg Oncol (1991) 0.91
Radiation treatment of cervical lymph node metastases from an unknown primary: an analysis of outcome by treatment volume and other prognostic factors. Radiother Oncol (1995) 0.89
Aggressive fibromatosis: optimisation of local management with a retrospective failure analysis. Radiother Oncol (1995) 0.88
Adenocarcinoma of the rectum treated by radical external radiation therapy. Int J Radiat Oncol Biol Phys (1995) 0.88
Shigella sonnei: another cause of sexually acquired reactive arthritis. Int J STD AIDS (2002) 0.88
Bias and the association of mammographic parenchymal patterns with breast cancer. Br J Cancer (1982) 0.88
A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer. Support Care Cancer (2000) 0.87
A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck. Laryngoscope (1999) 0.87
Ethmoid sinus cancer: twenty-nine cases managed with primary radiation therapy. Int J Radiat Oncol Biol Phys (1998) 0.86
Soft tissue sarcoma of the extremity. Limb salvage after failure of combined conservative therapy. Radiother Oncol (1996) 0.86
[Solid pseudopapillary tumors of the pancreas. Pathology report of 13 cases]. Gastroenterol Clin Biol (1999) 0.86
Neuropathological changes in the substantia nigra in schizophrenia but not depression. Eur Arch Psychiatry Clin Neurosci (2013) 0.85
The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift. Oncogene (1991) 0.85
Prognostic factors in clinical decision making: the future. Cancer (2001) 0.84
Histological necrosis in soft tissue sarcoma following preoperative irradiation. J Surg Oncol (1994) 0.84
Management of long-term postirradiation periclavicular complications. J Surg Oncol (1992) 0.84
Intradermal injection of autologous dermal fibroblasts improves wound healing in irradiated skin. J Surg Res (1999) 0.84
Are treatment strategies of urologic oncologists influenced by the opinions of their colleagues? Br J Cancer (1990) 0.83
Mammographic patterns and breast cancer risk: methodologic standards and contradictory results. J Natl Cancer Inst (1984) 0.82
Metachronous squamous-cell carcinoma of the colon and treatment of rectal squamous carcinoma with chemoradiotherapy. Colorectal Dis (2008) 0.82
Functional outcome in limb-salvage surgery for soft tissue tumours of the foot and ankle. Sarcoma (1997) 0.82
Situs inversus totalis and corrected transposition of the great arteries [I,D,D] in association with a previously unreported vascular ring. Pediatr Cardiol (2001) 0.82
Cost-effectiveness of intensity-modulated radiotherapy in oropharyngeal cancer. Clin Oncol (R Coll Radiol) (2012) 0.81
The role of computed tomography in the T classification of laryngeal carcinoma. Cancer (2001) 0.81
Quality of life and utility in irradiated laryngeal cancer patients. Int J Radiat Oncol Biol Phys (2000) 0.81
Managing extensive Fournier's gangrene secondary to bilateral, inguinal hernias. J Plast Reconstr Aesthet Surg (2008) 0.81
Mitomycin in anal canal carcinoma. Oncology (1993) 0.80
Topical diphenylhydantoin sodium can improve healing in a diabetic incisional animal wound model. J Wound Care (2007) 0.80
Mammographic patterns and bias in breast cancer detection. Radiology (1982) 0.79
Orthotopic liver transplantation for epithelioid haemangioendothelioma. Eur J Surg Oncol (2007) 0.79